Tuesday, August 14, 2012    |    BIO-IT World    |    Archives    |    Advertising   |    CHI Conferences    |    Subscribe 


How the FDA Stymies Progress -- and How to Get Around It
The Skeptical Outsider | Are cells taken from your body and then returned to it "drugs"?
They are, according to a recent court ruling that granted the FDA an injunction against
the developers of an adult stem cell therapy. And that doesn't sit well with the
"Skeptical Outsider," Bill Frezza. Read More 



Nic Volker, Living on the Edge of Science
JS Online | Two years after exome sequencing prompted a life-saving cord blood
transplant, 7-year-old Wisconsinite Nic Volker is enjoying school, real food, good health
and life in general. Read More

Researchers Germinate Novel Approach to Big Bio Data
Datanami | C. Titus Brown heads MSU's lab for Genomics, Evolution, and Development,
which recently undertook the task of researching large collections of metagenomics data.
The project was so complex that Brown's team had to fashion a solution to solve a specific
problem. Read More

Eric Schadt: Why Biology Needs a Steve Jobs
Nature Biotechnology | Eric Schadt, director of Mount Sinai's new Institute for Genomics
and Multiscale Biology, discusses his vision to spend $100 million launching Mount Sinai
to the forefront of the genomics revolution - and why he's enlisting Wall Street quants,
user interface gurus and Facebook's former data whiz to do it. Read More

Found in Translation: Where Do Cures Come From?
The Guardian | In this opinion piece, Jenny Rohn asks, What's the best way of doing
research? Throwing money at bright minds or trying to solve a particular problem? Or is
there a third way? Read More

Clinical Trial is Favorable for Microarray Prenatal Gene Test   
 New York Times | The use of microarrays for prenatal testing to detect more genetic
problems in a fetus than standard kayrotype testing could be headed toward wider
use after encouraging results
from an NIH-sponsored clinical trial of more than 4,000
pregnancies. Read More

Physicians May Not Be Social, But They are Interactive    
 Forbes.com | The desire to understand physician behavior, identify Key Opinion Leaders,
and reach those influencers in a measured way is of extreme importance to
pharmaceutical executives, writes Jim Golden in his latest blog. Read More

CardioDx Wins Medicare OK of Molecular Test for Heart Disease   
Xconomy | After three years marketing a new genetic test that can tell when a patient's
chest pain is a sign of serious heart disease, CardioDX has taken a big step forward by
persuading Palmetto GBA, the national contractor for Medicare, to reimburse the company
for its Corus CAD test. Read More